EP0975612A4 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
EP0975612A4
EP0975612A4 EP98919821A EP98919821A EP0975612A4 EP 0975612 A4 EP0975612 A4 EP 0975612A4 EP 98919821 A EP98919821 A EP 98919821A EP 98919821 A EP98919821 A EP 98919821A EP 0975612 A4 EP0975612 A4 EP 0975612A4
Authority
EP
European Patent Office
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98919821A
Other languages
German (de)
French (fr)
Other versions
EP0975612A1 (en
Inventor
Kevin J Duffy
Scott K Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0975612A1 publication Critical patent/EP0975612A1/en
Publication of EP0975612A4 publication Critical patent/EP0975612A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
EP98919821A 1997-04-15 1998-04-15 Protease inhibitors Withdrawn EP0975612A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4309697P 1997-04-15 1997-04-15
US43096P 1997-04-15
US4453197P 1997-04-23 1997-04-23
US44531P 1997-04-23
PCT/US1998/007969 WO1998046582A1 (en) 1997-04-15 1998-04-15 Protease inhibitors

Publications (2)

Publication Number Publication Date
EP0975612A1 EP0975612A1 (en) 2000-02-02
EP0975612A4 true EP0975612A4 (en) 2001-06-13

Family

ID=26720044

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98919821A Withdrawn EP0975612A4 (en) 1997-04-15 1998-04-15 Protease inhibitors

Country Status (7)

Country Link
EP (1) EP0975612A4 (en)
JP (1) JP2002515902A (en)
AR (1) AR012374A1 (en)
AU (1) AU7252398A (en)
CA (1) CA2285601A1 (en)
CO (1) CO4950541A1 (en)
WO (1) WO1998046582A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325114T1 (en) * 1999-06-22 2006-06-15 Takeda Pharmaceutical ACYLHYDRAZINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
SK13632002A3 (en) 2000-03-21 2003-02-04 Smithkline Beecham Corporation C1-6-alkyl-4-amino-azepan-3-one compounds, process for the preparation thereof, pharmaceutical composition comprising the same and intermediates
HN2002000136A (en) 2001-06-11 2003-07-31 Basf Ag INHIBITORS OF THE PROTEASE OF HIV VIRUS, COMPOUNDS CONTAINING THEMSELVES, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR SYNTHESIS
US7282512B2 (en) 2002-01-17 2007-10-16 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
US8551992B2 (en) 2011-05-27 2013-10-08 Neosome Life Sciences, LLC Aminooxazole inhibitors of cyclin dependent kinases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755937B2 (en) * 1986-07-29 1995-06-14 日本曹達株式会社 Oxa (thia) zolidine derivative, its production method and acaricide
US5244867A (en) * 1989-09-26 1993-09-14 Basf Aktiengesellschaft Oxazole- and thiazolecarboxamides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9846582A1 *
THOMPSON S K ET AL: "Design of potent and selective human cathepsin K inhibitors rhat span the active site", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, no. 26, 23 December 1997 (1997-12-23), pages 14249 - 14254, XP002913847 *

Also Published As

Publication number Publication date
WO1998046582A1 (en) 1998-10-22
AU7252398A (en) 1998-11-11
CO4950541A1 (en) 2000-09-01
EP0975612A1 (en) 2000-02-02
AR012374A1 (en) 2000-10-18
JP2002515902A (en) 2002-05-28
CA2285601A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
PL336625A1 (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
PL349192A1 (en) Protease inhibitors
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL328307A1 (en) Serinic protease inhibitors
EP0744948A4 (en) Protease inhibitors
IL132088A0 (en) Protease inhibitors
PL337755A1 (en) Protease inhibitors
EP1093367A4 (en) Protease inhibitors
ZA983522B (en) Protease inhibitors
ZA988479B (en) Protease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
EP1067894A4 (en) Protease inhibitors
EP1079821A4 (en) Protease inhibitors
ZA988064B (en) Protease inhibitors
HK1041690A1 (en) Protease inhibitors
EP1086083A4 (en) Protease inhibitors
EP0975612A4 (en) Protease inhibitors
ZA983097B (en) Protease inhibitors
ZA977032B (en) Protease inhibitors
GB9420277D0 (en) Protease inhibitors
GB9727371D0 (en) Inhibitors
GB9709064D0 (en) Inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20010502

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 417/12 A, 7C 07D 417/14 B, 7C 07K 5/06 B, 7A 61K 31/425 B, 7A 61K 31/47 B, 7A 61K 38/05 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010730